Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-kappaB, cyclooxygenase 2, and matrix metalloprotease 9 - PubMed (original) (raw)
. 2002 Sep 1;62(17):4945-54.
Affiliations
- PMID: 12208745
Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-kappaB, cyclooxygenase 2, and matrix metalloprotease 9
Sanjeev Banerjee et al. Cancer Res. 2002.
Abstract
We have reported recently that resveratrol (trans-3,4',5-trihydroxystilbene), a polyphenolic phytoalexin found in grapes, fruits, and root extracts of the weed Polygonum cuspidatum, is a potent inhibitor of nuclear factor (NF)-kappaB activation. Because NF-kappaB suppression has been linked with chemoprevention, this prompted us to investigate the chemopreventive potential of resveratrol by testing it against mammary carcinogenesis induced by 7,12-dimethylbenz(a)anthracene (DMBA) in female Sprague Dawley rats. Dietary administration of resveratrol (10 ppm) had no effect on body weight gain and tumor volume but produced striking reductions in the incidence (45%; P < 0.05), multiplicity (55%; P < 0.001), and extended latency period of tumor development relative to DMBA-treated animals. Histopathological analysis of the tumors revealed that DMBA induced ductal carcinomas and focal microinvasion in situ (7 of 7), whereas treatment with resveratrol suppressed DMBA-induced ductal carcinoma. Immunohistochemistry and Western blot analysis revealed that resveratrol suppressed the DMBA-induced cyclooxygenase-2 and matrix metalloprotease-9 expression in the breast tumor. Gel shift analysis showed suppression of DMBA-induced NF-kappaB activation by resveratrol. Treatment of human breast cancer MCF-7 cells with resveratrol also suppressed the NF-kappaB activation and inhibited proliferation at S-G(2)-M phase. Overall, our results suggest that resveratrol suppresses DMBA-induced mammary carcinogenesis, which correlates with down-regulation of NF-kappaB, cyclooxygenase-2, and matrix metalloprotease-9 expression.
Similar articles
- Dose-response effects of the COX-2 inhibitor, celecoxib, on the chemoprevention of mammary carcinogenesis.
Abou-Issa HM, Alshafie GA, Seibert K, Koki AT, Masferrer JL, Harris RE. Abou-Issa HM, et al. Anticancer Res. 2001 Sep-Oct;21(5):3425-32. Anticancer Res. 2001. PMID: 11848504 - Role of 5-lipoxygenase in resveratrol mediated suppression of 7,12-dimethylbenz(α)anthracene-induced mammary carcinogenesis in rats.
Chatterjee M, Das S, Janarthan M, Ramachandran HK, Chatterjee M. Chatterjee M, et al. Eur J Pharmacol. 2011 Oct 1;668(1-2):99-106. doi: 10.1016/j.ejphar.2011.06.039. Epub 2011 Jul 6. Eur J Pharmacol. 2011. PMID: 21749863 - Genistein and resveratrol: mammary cancer chemoprevention and mechanisms of action in the rat.
Whitsett TG Jr, Lamartiniere CA. Whitsett TG Jr, et al. Expert Rev Anticancer Ther. 2006 Dec;6(12):1699-706. doi: 10.1586/14737140.6.12.1699. Expert Rev Anticancer Ther. 2006. PMID: 17181483 Review. - Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies.
Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S, Takada Y. Aggarwal BB, et al. Anticancer Res. 2004 Sep-Oct;24(5A):2783-840. Anticancer Res. 2004. PMID: 15517885 Review.
Cited by
- Properties of Resveratrol: In Vitro and In Vivo Studies about Metabolism, Bioavailability, and Biological Effects in Animal Models and Humans.
Gambini J, Inglés M, Olaso G, Lopez-Grueso R, Bonet-Costa V, Gimeno-Mallench L, Mas-Bargues C, Abdelaziz KM, Gomez-Cabrera MC, Vina J, Borras C. Gambini J, et al. Oxid Med Cell Longev. 2015;2015:837042. doi: 10.1155/2015/837042. Epub 2015 Jun 28. Oxid Med Cell Longev. 2015. PMID: 26221416 Free PMC article. Review. - Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence.
Tomé-Carneiro J, Larrosa M, González-Sarrías A, Tomás-Barberán FA, García-Conesa MT, Espín JC. Tomé-Carneiro J, et al. Curr Pharm Des. 2013;19(34):6064-93. doi: 10.2174/13816128113199990407. Curr Pharm Des. 2013. PMID: 23448440 Free PMC article. Review. - Resveratrol given intraperitoneally does not inhibit the growth of high-risk t(4;11) acute lymphoblastic leukemia cells in a NOD/SCID mouse model.
Zunino SJ, Storms DH, Newman JW, Pedersen TL, Keen CL, Ducore JM. Zunino SJ, et al. Int J Oncol. 2012 Apr;40(4):1277-84. doi: 10.3892/ijo.2011.1316. Epub 2011 Dec 22. Int J Oncol. 2012. PMID: 22200740 Free PMC article. - Resveratrol: a review of preclinical studies for human cancer prevention.
Athar M, Back JH, Tang X, Kim KH, Kopelovich L, Bickers DR, Kim AL. Athar M, et al. Toxicol Appl Pharmacol. 2007 Nov 1;224(3):274-83. doi: 10.1016/j.taap.2006.12.025. Epub 2007 Jan 3. Toxicol Appl Pharmacol. 2007. PMID: 17306316 Free PMC article. Review. - Genistein and resveratrol, alone and in combination, suppress prostate cancer in SV-40 tag rats.
Harper CE, Cook LM, Patel BB, Wang J, Eltoum IA, Arabshahi A, Shirai T, Lamartiniere CA. Harper CE, et al. Prostate. 2009 Nov 1;69(15):1668-82. doi: 10.1002/pros.21017. Prostate. 2009. PMID: 19670229 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials